Early detection doesn’t get enough attention and a transatlantic research alliance is about to change that. The UK’s University of Cambridge takes up a central role in a £55 million transatlantic research alliance to develop novel new strategies and technology in the quest to detect cancer as early as possible. Cancer Research UK (CRUK) will invest up to £40 million over 5 years into the alliance with American partners contributing another £15 million. Called the International Alliance for Cancer Early Detection (ACED), it involves a partnership between CRUK, the Canary Center at Stanford University, the University of Cambridge, OHSU Knight Cancer Institute, UCL, and the University of Manchester.
Research Goals: New Screening Technologies for Hard to Detect Cancers
This transatlantic team comes together with an aim to accelerate breakthroughs in early detection of cancer, which is known to dramatically improve a patient’s odds of survival. For example, the medical industry understands that current screening programs for bowel, breast and cervical cancers had had considerable impact, along with improved public awareness and urgent GP referrals for those with suspicious ...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).